Palisade Bio Operating Margin Growth & History (PALI)

Palisade Bio's operating margin was −5,228.00% for fiscal 2023.

View full Palisade Bio company overview

Palisade Bio annual operating margin history

Palisade Bio annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20232023-12-31−5,228.00%+63536.79 pp
20202020-12-31−68,764.79%−12692.99 pp
20192019-12-31−56,071.81%−52895.09 pp
20182018-12-31−3,176.71%+1941.40 pp
20172017-12-31−5,118.12%+121909.11 pp
20162016-12-31−127,027.23%+56869.56 pp
20152015-12-31−183,896.78%−91315.42 pp
20142014-12-31−92,581.37%−81195.97 pp
20132013-12-31−11,385.40%−8894.29 pp
20122012-12-31−2,491.11%+834.45 pp
20112011-12-31−3,325.56%−1255.19 pp
20102010-12-31−2,070.37%

Palisade Bio operating margin trends

Over the last five reported fiscal years, Palisade Bio's operating margin increased from −127,027.23% to −5,228.00%, a change of +121799.23 percentage points. The latest reported quarter, Q2 2026, shows −2,339.60%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Palisade Bio filings at SEC.gov ↗